Melatonin (N-acetyl-5-methoxytryptamine) is a ubiquitous molecule present in animals and plants, and also in bacteria and fungi. In plants, it has an important regulatory and protective role in the face of different stress situations in which it can be involved, mainly due to its immobility. Both in the presence of biotic and abiotic stressors, melatonin exerts protective action in which, through significant changes in gene expression, it activates a stress tolerance response. Its anti-stress role, along with other outstanding functions, suggests its possible use in active agricultural management. This review establishes considerations that are necessary for its possible authorization. The particular characteristics of this substance and its categorization as plant biostimulant are discussed, and also the different legal aspects within the framework of the European Community. The advantages and disadvantages are also described of two of its possible applications, as a plant protector or biostimulant, in accordance with legal provisions.
Introduction
Melatonin (N-acetyl-5-methoxytryptamine) is a biogenic amine derived from the amino acid tryptophan, which was discovered in 1958 in the cow pineal gland by Lerner and cols. [1] . Two years later, it was detected in humans and its chemical structure was elucidated. This molecule, which was initially only related to changes in the structure of melanocytes in amphibians, fish and reptiles, was soon found to act as a neurohormone in mammals [2, 3] . Since its discovery it has become one of the most researched molecules. In animals, it presents a multitude of physiological actions such as a role in the circadian rhythms of several molecules, and its influence on sleep-wake cycles, mood, motor activity and body temperature changes [4] [5] [6] [7] . Its influence on food intake and its relationship with metabolic syndrome has also been demonstrated [8] [9] [10] . In other more specific situations such as the physiology of the retina, the immune system, sexual behavior and as an anti-cancer effector, melatonin also has a relevant role [11] [12] [13] [14] [15] . In addition, interesting and extensive reviews on the role of melatonin in animals and humans can be consulted [16] [17] [18] [19] [20] [21] [22] [23] .
In 1995, the presence of melatonin in plants was discovered [24] [25] [26] [27] . During the following years there was much reluctance on the part of researchers to accept this, since some refused to believe that a neurohormone could be present in plants, and much less that it had any role in their physiology.
A key piece was the elucidation of the melatonin biosynthesis route in plants, localized between the mitochondria, chloroplasts and cytoplasm of cells, and which has been studied with great accuracy by K. Back and J. Kong in rice and Arabidopsis plants [28] [29] [30] . However, it is now fully accepted that melatonin is present in all plant species and that it presents a panoply of interesting actions. Indeed, (JA) and polyamines [31] [32] [33] 35, 38, 69, [71] [72] [73] [74] [75] . In general, subjecting plants to a stressful situation-which leads to an increase in endogenous levels of melatonin-or treatment with exogenous melatonin, results in a stress tolerance response mediated by specific stress response factors and changes in the endogenous levels of plant hormones involved in the response [31] [32] [33] [34] [35] [36] 38, [40] [41] [42] [43] [75] [76] [77] [78] [79] [80] [81] [82] [83] [84] [85] . In addition, the recent identification of a melatonin receptor in Arabidopsis thaliana has opened new expectations related to its role as a new plant hormone [86] . Figure 1 shows these aspects in a condensed form. 
Beneficial Responses to Melatonin Treatments in Different Crops in Stress Situations
Studies conducted with melatonin in plants under both abiotic and biotic stress are numerous. Table 1 compiles many of the studies with an agronomic interest since they deal primarily with crop species for human consumption. Table 1 presents studies classified by plant species, where there are many physiological aspects that are investigated in which melatonin exerts some generally beneficial action. These include seed germination, the growth and vegetative development of plants; photosynthesis, its pigments, photorespiration, stomatic conductance and water economy; the yields of seeds and fruits in adverse conditions; osmoregulation, ion exchange and adjustments in osmotic and hydric potentials, and the regulation of the different metabolisms of carbohydrates, lipids, nitrogen compounds, sulfur and phosphorus cycles. In regards to the secondary metabolism, melatonin induces the biosynthesis of flavonoids, anthocyanins and carotenoids, among others; in hormonal homeostasis, it intervenes in the regulation of all plant hormones and its own biosynthesis. It promotes the rooting process of primary, secondary and adventitious roots while during foliar senescence, melatonin regulates the expression of chlorophyll degradation-related and senescence-induced genes. In the postharvest control of fruits, melatonin increases the ethylene and lycopene content, and regulates many enzymes of the cell wall, ethylene biosynthesis, and primary 
Studies conducted with melatonin in plants under both abiotic and biotic stress are numerous. Table 1 compiles many of the studies with an agronomic interest since they deal primarily with crop species for human consumption. Table 1 presents studies classified by plant species, where there are many physiological aspects that are investigated in which melatonin exerts some generally beneficial action. These include seed germination, the growth and vegetative development of plants; photosynthesis, its pigments, photorespiration, stomatic conductance and water economy; the yields of seeds and fruits in adverse conditions; osmoregulation, ion exchange and adjustments in osmotic and hydric potentials, and the regulation of the different metabolisms of carbohydrates, lipids, nitrogen compounds, sulfur and phosphorus cycles. In regards to the secondary metabolism, melatonin induces the biosynthesis of flavonoids, anthocyanins and carotenoids, among others; in hormonal homeostasis, it intervenes in the regulation of all plant hormones and its own biosynthesis. It promotes the rooting process of primary, secondary and adventitious roots while during foliar senescence, melatonin regulates the expression of chlorophyll degradation-related and senescence-induced genes. In the postharvest control of fruits, melatonin increases the ethylene and lycopene content, and regulates many enzymes of the cell wall, ethylene biosynthesis, and primary and secondary metabolisms. It also helps preserve cut flowers; in fruiting it induces parthenocarpy. Finally, its role in bacterial, fungal and viral pathogenic infection should be emphasized, slowing damage and stimulating systemic acquired resistance (SAR) to favor crop health.
Obviously, all the above plant physiology aspects are of interest for application in plant production. Indeed, while many of the above studies were at a laboratory level, others have already been put into practice in crops with excellent results.
In general, exogenous melatonin applications are made through the root system, in irrigation water, or by spraying leaves. In the last case, no adjuvant is needed since melatonin is an amphipathic molecule that crosses biological membranes and the waxy cuticles. Melatonin is transported via the xylem from the roots to the rest of the organs of the plant quite effectively [87, 88] . Cold-fruit 100 ↑ tolerance, proline, polyamines, membrane integrity [205] ↑ thermotolerance and cell protection [206, 207] Heat-pollen 20 ↑ thermotolerance, polen germination, antioxidant enzymes, reproductive development [208] Metal-Cd 25-500 ↑ Cd tolerance, phytochelatins, ATPase activity [209] Metal-Cd -↑ Cd tolerance, heat-shock factor A1a induction by melatonin [210] Metal-Cd-Se -↑ growth, photosynthesis, electrolyte leakage, phytochelatins, GSH, ↓ ROS, Cd leaf, 
Melatonin in the Health and Environment of EC
In accordance with the Classification, Labelling and Packaging (CLP, EC-No 1272/2008) regulation, which is based on the United Nations' Globally Harmonized System, which has a purpose to ensure a high level of protection of health and the environment, as well as the free movement of substances, mixtures and articles, the European Chemical Agency (ECHA) classified melatonin (EC No. 200-797-7 (CAS 73-31-4), N-(2-(5-methoxyindol-3-yl)-ethyl)-acetamide), as a non-hazardous substance in terms of physical and chemical hazards. With respect to human health, it is classified as a non-hazardous substance in the oral, dermal, inhalation and irritation categories, and in regards to mutagenicity and carcinogenicity. However, melatonin is classified as a health hazard substance (code H-361) in terms of reproductive toxicity because it is suspected of damaging fertility or an unborn child. This classification reflects one of its multiple functions as an animal hormone, in which its participation in the modulation of sexual behavior in mammals has been demonstrated, and also, it is believed, the same of fertility [233, 234] . In fact, it is usually applied to sheep as a hormonal regulator of sexual zeal to homogenize the reproductive process in ovine, with demonstrated higher conception and pregnancy rates when applied [235] . Nevertheless, melatonin is classified as non-hazardous in terms of its possible damage to the environment and atmosphere.
Melatonin as an Active Substance or as a Plant Biostimulator/Protector in Crops: Concepts and Legal Considerations in EC
After many changes and adaptations, the EC finally seems to have established its policy regarding the authorization, classification, use, distribution, importation, management, etc., of plant protectors and fertilizers, in an attempt to improve agricultural production, while minimizing risks and hazards for humans, animals and the environment. In order to establish the minimum basis for the possible use of melatonin in plant production and post-harvest application, several requirements regarding its human consumption must be taken into account:
(i) Melatonin is a highly studied substance that has given rise to abundant physicochemical and biological data; (ii) there are numerous studies in animals and humans regarding its beneficial effects on health, in aspects as diverse as neurodegenerative, immunological, liver, renal, heart, skin and gastrointestinal diseases, in addition to osteopathy, retinopathy, etc. It also helps in the treatment of various cancers, particularly, chemical and radiological therapies; (iii) in regards to melatonin for human consumption, although it is classified as a drug in the EC, there are some cases in which it does not need a medical prescription, such as those where the amount of melatonin is less than 1 mg. Generally, these are used for jet-lag and sleep disorders. In many other countries (e.g., USA, Canada) melatonin is not treated as a drug, but as a food supplement; (iv) in no case has melatonin been declared as toxic, even at the intake of 1 g/day. Only some slight side effects such as migraine and headache have been described.
The possible use of melatonin in plant production involves particular aspects such as: (i) Melatonin is a molecule that exists in all living things, from bacteria to humans, but also in plants, algae, fungi, etc.; (ii) its action in animals and humans is well known since it has been investigated for many years. In plants, although many physiological effects of melatonin are known, new data are being acquired every day; (iii) in all cases, only positive effects have been described, all beneficial for the development of plants (the same can be said for animals); (iv) little information is available on its effect on bacteria and fungi, especially those that are part of the soil microbiota (rhizosphere); (v) there are also few or no data on its effect on the environment, in particular on agricultural and aquatic fauna; (vi) the levels of melatonin described in plants, and which appear to be effective in pharmacological treatments known to date, are much higher than those described in animals or humans, which may be a cause for caution.
Council Directive 91/414/EEC of 15 July, 1991 concerning the marketing of plant protection products provides rules governing plant protection products and the active substances contained in those products. This old directive has been replaced by two more current ones that are as follows: If we review the actions confirmed so far for melatonin in plants, we find that melatonin exerts a clear action as a plant protector in situations of biotic stress against bacterial, fungal and viral diseases (Regulation #2), but it can also be used as an agent against situations of abiotic stress (Regulation #1). Thus, Regulation #2 says in point 22:
"Certain substances, mixtures and micro-organisms, referred to as plant biostimulants, are not as such inputs of nutrients, but nevertheless stimulate plants' natural nutrition processes. Where such products aim solely at improving the plants' nutrient use efficiency, tolerance to abiotic stress, quality traits or increasing the availability of confined nutrients in the soil or rhizosphere, they are by nature more similar to fertilising products than to most categories of plant protection products. They act in addition to fertilisers, with the aim of optimising the efficiency of those fertilisers and reducing the nutrient application rates. Such products should therefore be eligible for CE marking under this Regulation and excluded from the scope of Regulation (EC) No 1107/2009". These two regulations attempt to classify the substances and products applicable to crops into two large groups: Those that are plant protectors (phyto-sanitary) (Regulation #1) and those that can be used as fertilizers (Regulation #2). As we have seen in the previous section, melatonin is classified as a health hazard substance (code H-361) for its reproductive toxicity in ECHA, so its possible authorization as an active substance by regulation EC 1907/2006 of Registration, Evaluation, Authorisation and Restriction of Chemicals (REACH) could be difficult.
Although Regulation #1 on plant protection products extends the concept of an active substance, since it includes microorganisms and preparations (art. 1 point 2): This Regulation shall apply to substances, including micro-organisms having general or specific action against harmful organisms or on plants, parts of plants or plant products, referred to as 'active substances', some interesting restrictions appeared in:
• Art. 23b: "Basic substances shall be approved in accordance with paragraphs 2 to 6. ( . . . ) For the purpose of paragraphs 2 to 6, a basic substance is an active substance which ( . . . ), (b) does not have an inherent capacity to cause endocrine disrupting, neurotoxic or immunotoxic effects"; • Annex II, Impact on Human Health, 3.6.5: "An active substance, safener or synergist shall only be approved if, on the basis of the assessment of community or internationally agreed test guidelines or other available data and information, including a review of the scientific literature, reviewed by the Authority, it is not considered to have endocrine disrupting properties that may cause adverse effect in humans, unless the exposure of humans to that active substance, safener or synergist in a plant protection product, under realistic proposed conditions of use, is negligible, . . . " and in; • Annex II. Ecotoxicology, 3.8.2. An active substance, safener or synergist shall only be approved if, on the basis of the assessment of community or internationally agreed test guidelines, it is not considered to have endocrine disrupting properties that may cause adverse effects on non-target organisms unless the exposure of non-target organisms to that active substance in a plant protection product under realistic proposed conditions of use is negligible.
Thus, taking into account all this legal information, and ruling out the possibility of using melatonin as an active substance (pure chemical substance) for agronomic application, the possibility of using plant, bacterial, algae, or fungi extracts rich in melatonin would remain. Thus, a good plan might be to use plant (or other) extracts rich in melatonin as a fertilizer, in the category of biostimulants. A biostimulant could also be defined as a formulated product of biological origin that improves plant productivity as a consequence of the emergent properties of its constituents. Thus, biostimulants could be defined by their demonstrated mode of action and origin, or solely by their demonstrated beneficial impact on plant productivity. The challenges in developing a definition are also complicated by the multi-component and largely undefined composition of many biostimulant products and the possibility that the activity of a biostimulant may not be explained by the presence of any individual constituent, but is a result of the interaction of many constituents in the product. Indeed, most biostimulants in use today are complex mixtures of chemicals derived from a biological process or the extraction of biological materials [236] .
According Regulation #2 (EU 2019/1009) on fertilizing products, in Annex I, Product Function Categories (PFCs) of EU fertilizing products, in Category 6, two types of plant biostimulant can be developed: Microbial plant biostimulants (subtype A) and non-microbial plant biostimulants (subtype B). In Annex II, it says: "An EU fertilizing product shall consist solely of component materials complying with the requirements for one or more of the CMCs listed in this Annex", where the different component materials categories (CMC) were defined. Of interest are the following:
• CMC2: Plants, plant parts or plant extracts is described as: "An EU fertilizing product may contain plants, plant parts or plant extracts having undergone no other processing than cutting, grinding, milling, sieving, sifting, centrifugation, pressing, drying, frost treatment, freeze-drying or extraction with water or supercritical CO 2 extraction. For the purpose of this point, plants include mushrooms and algae and exclude blue-green algae (cyanobacteria)." • CMC6: Food industry by-products, point (e): "Plants, plant parts or plant extracts having undergone only heat treatment or heat treatment in addition to processing methods referred to in CMC 2" • CMC7: Micro-organisms. "An EU fertilising product belonging to PFC 6A may contain micro-organisms, including dead or empty-cell micro-organisms and non-harmful residual elements of the media on which they were produced".
The strategies to obtain melatonin-rich extracts may involve microorganisms (PFC6A) or plants (PFC 6B). At present, there seem to be no data on the production of melatonin by bacteria or fungal cultures. The objective to obtain melatonin-rich plants (CMC2) is ambitious since phytomelatonin levels in plants are usually very low, and less than 5-10 ng per gram of plant. An exhaustive classification of many plants according to their phytomelatonin content can be consulted [37, 237, 238] . Generally, medicinal plants have high phytomelatonin content, but this tends to vary widely due to the varied origin of plants, technical conditions of growth, variety, post-harvest treatment, etc. Several strategies can be followed: (i) Selecting plant species with high levels of phytomelatonin which can be extracted and concentrated, and (ii) inducing the biosynthesis of phytomelatonin in in vitro cultured pre-selected plant tissues. A discussion on this aspect can be consulted [239] . Our group is developing a formulation where only aromatic/medicinal plants are used to obtain a botanical mixture rich in phytomelatonin through the application of a simple process. A rigorous plant selection protocol and careful management will ensure high phytomelatonin content in the plant extracts generated. The formulation and its protocol are being patented before being made available to interested companies for commercial exploitation. We are currently characterizing it and conducting the appropriate studies and bioassays in plants to confirm its beneficial biological activity related with its high phytomelatonin content. Figure 2 shows, according to the legislation analyzed, the pros and cons of melatonin (as a chemical substance) and phytomelatonin-rich extracts and its possible regularization as a plant protector or fertilizer (biostimulant). Figure 2 shows, according to the legislation analyzed, the pros and cons of melatonin (as a chemical substance) and phytomelatonin-rich extracts and its possible regularization as a plant protector or fertilizer (biostimulant). 
Future Prospects
Numerous studies with melatonin have resulted in a set of data that indicate the excellent beneficial effects that this compound has on plants, especially in stress situations. It should not be forgotten that melatonin is a natural compound, endogenous to plants and other organisms including humans. It is this last aspect that makes it more interesting and also more delicate or sensitive, when using it as a plant protective agent or as a biostimulator. However, demonstrating through trials that its use is possible in crops and does not entail risks to human and wildlife health will be the only way forward in this field. The alternative of using phytomelatonin-rich extracts seems more interesting, but also more laborious. The search and selection of plants with high endogenous levels of phytomelatonin is a first requirement for subsequent extraction and preparation. The analysis and study of its potential as a protector against plant stress will throw light on the true effect on crops. However, although many aspects of the mechanism of action of phytomelatonin are already known, there are other relevant aspects to study as: (i) The optimal mode of application, time and rate; (ii) the phenological state; (iii) the effect on rhizosphere; (iv) the persistence in soil or in foliar applications; (v) the synergic or antagonic effects with other plant treatments (pesticides, fertilizers, etc.), among others. Obviously, companies in the phytochemical sector (manufacturers) will need to start field studies and deal with possible legal regularization. 
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